Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition.

Cell chemical biology | 2018

Nicotinamide adenine dinucleotide (NAD) levels decrease with aging as a result of aging-associated CD38 upregulation. Here, we established a cell model with decreased cellular NAD levels by overexpressing CD38 or treating cells with FK866, an inhibitor of nicotinamide phosphoribosyltransferase. We revealed that decreased NAD triggered reactive oxygen species (ROS)-mediated degradation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which drove cells to undergo epithelial-mesenchymal transition (EMT). Moreover, we showed that oxidation of the Cys44 residue to sulfonic acid in 15-PGDH led to its degradation via non-canonical ubiquitination-proteasome and autophagy pathways. Mutation of Cys44 to alanine abolished ROS-induced 15-PGDH degradation. We demonstrated that 15-PGDH silencing promoted EMT, whereas supplementation with NAD precursors increased NAD and 15-PGDH stability, and reversed the EMT process. Taken together, these results suggest that declining NAD levels contribute to age-dependent increases in cancer incidence, and repletion of NAD precursors is beneficial for increasing 15-PGDH expression.

Pubmed ID: 29307841 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PARP-1 (F-2) (antibody)

RRID:AB_628105

This monoclonal targets Genetic locus: PARP1 (human) mapping to 1q42.12.

View all literature mentions

Vimentin antibody (antibody)

RRID:AB_2273020

This polyclonal targets Vimentin

View all literature mentions

ZO-1 antibody (antibody)

RRID:AB_10733242

This polyclonal targets ZO-1

View all literature mentions

SirT1 (C14H4) Rabbit mAb (antibody)

RRID:AB_2285964

This monoclonal targets Human SirT1

View all literature mentions

SQSTM1/p62 Antibody (antibody)

RRID:AB_10624872

This polyclonal targets SQSTM1/p62

View all literature mentions

N-Cadherin (D4R1H) XP Rabbit Antibody (antibody)

RRID:AB_2687616

This monoclonal targets N-Cadherin

View all literature mentions

β-Actin (13E5) Rabbit mAb (antibody)

RRID:AB_2223172

This monoclonal targets beta-Actin

View all literature mentions

E Cadherin antibody [HECD-1] (antibody)

RRID:AB_300946

This monoclonal targets E Cadherin

View all literature mentions